Welcome to ToeFX
We are revolutionizing regenerative medicine, biobanking and drug discovery by increasing the viability of biologics.
Growing with purpose
- 2002 – Commenced trading as a public company
- 2014 – Uplisted to NASDAQ National Market
- 2019 – Acquired automated, water-free thawing company (Astero Bio)
- 2019 – Acquired cloud-connected shipping company (SAVSU Technologies)
- 2019 – Acquired cryogenic storage freezer company (Custom Biogenic Systems)
- 2020 – Acquired biostorage services company (SciSafe)
- 2021 – Acquired ultra-low temperature freezer company (Stirling Ultracold)
- 2021 – Acquired cell and gene therapy manufacturing solutions company (Sexton Biotechnologies).
At Biolife Solutions, we employ more than 400 dedicated team members who come to work every day thinking about our customers and what we can do to offer more value.
Guiding values
» Our team members are our most important asset
» We only employ motivated, inspired people who thrive in a performance-based environment.
» Honesty, integrity, and authentic communication are expected and required for continued employment
» We challenge every team member continuously exceed customer expectations
» Our quality environment can and will be continuously improved
» We strive to maintain financial performance consistent with maximizing shareholder value
Quality management system
At BioLife Solutions, Inc., we are committed to class-defining Best Practices in Quality. Our focus on developing and understanding critical quality elements, maintaining ongoing process controls, and creating a culture of continuous improvement, ensures that customers can rely on us to consistently meet their specification and requirements.
